Novartis Ag (NVS) Current Leases (2019 - 2026)

Novartis Ag (NVS) has 8 years of Current Leases data on file, last reported at $271.0 million in Q1 2026.

• Quarterly Current Leases rose 11.98% year-over-year to $271.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $271.0 million (up 11.98% YoY) and the FY2025 annual result came in at $263.0 million, up 11.91% from the prior year.
• Current Leases grew to $271.0 million in Q1 2026 per NVS's latest filing, from $263.0 million in the prior quarter.
• The five-year high for Current Leases was $1.6 billion in Q2 2025, with the low at $210.0 million in Q3 2023.
• Average Current Leases over 5 years is $556.5 million, with a median of $251.0 million recorded in 2022.
• Year-over-year, Current Leases declined 15.32% in 2023 and advanced 17.62% in 2024.
• Novartis Ag's Current Leases stood at $251.0 million in 2022, then retreated by 8.37% to $230.0 million in 2023, then advanced by 2.17% to $235.0 million in 2024, then rose by 11.91% to $263.0 million in 2025, then grew by 3.04% to $271.0 million in 2026.
• Business Quant data shows NVS's Current Leases at $271.0 million in Q1 2026, $263.0 million in Q4 2025, and $264.0 million in Q3 2025.